Literature DB >> 28732587

The skin as a window to the blood: Cutaneous manifestations of myeloid malignancies.

Alvin W Li1, Emily S Yin1, Maximilian Stahl2, Tae Kon Kim2, Gauri Panse1, Amer M Zeidan2, Jonathan S Leventhal3.   

Abstract

Cutaneous manifestations of myeloid malignancies are common and have a broad range of presentations. These skin findings are classified as specific, due to direct infiltration by malignant hematopoietic cells, or non-specific. Early recognition and diagnosis can have significant clinical implications, as skin manifestations may be the first indication of underlying hematologic malignancy, can reflect the immune status and stage of disease, and cutaneous reactions may occur from conventional and targeted agents used to treat myeloid disease. In addition, infections with cutaneous involvement are common in immunocompromised patients with myeloid disease. Given the varying presentations, dermatologic findings associated with myeloid malignancies can pose diagnostic challenges for hematologists and dermatologists. In this clinical review intended for the practicing hematologist/oncologist, we discuss the presentation, diagnosis, treatment, and prognostic value of the most common cutaneous manifestations associated with myeloid malignancies using illustrative macro- and microscopic figures and with a special emphasis on practical considerations.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dermatology; Leukemia; Leukemia cutis; Myeloid malignancies; Paraneoplastic; Skin

Mesh:

Year:  2017        PMID: 28732587     DOI: 10.1016/j.blre.2017.07.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  8 in total

Review 1.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

2.  CAN SKIN BE A MARKER FOR INTERNAL MALIGNANCY? EVIDENCE FROM CLINICAL CASES.

Authors:  Liborija Lugović-Mihić; Mirela Krišto; Sanja Špoljar; Gaby Novak-Bilić; Iva Bešlić; Majda Vučić; Mirna Šitum
Journal:  Acta Clin Croat       Date:  2021-12       Impact factor: 0.932

3.  Leukemia Cutis in Chronic Neutrophilic Leukemia Associated with Colony Stimulating Factor 3 Receptor Mutation: Clinical Severity Paralleled with Hematologic Abnormality.

Authors:  Osung Kwon; Joonsoo Park; Hyun Chung; Kyung Duck Park
Journal:  Ann Dermatol       Date:  2019-10-31       Impact factor: 1.444

Review 4.  Immune-Mediated Cutaneous Paraneoplastic Syndromes Associated With Hematologic Malignancies: Skin as a Mirror of Hematologic Neoplasms.

Authors:  Jose C Alvarez-Payares; Angel Molina; Simon Gallo; Julian Ramirez; Juan Hernandez; Fernando Lopez; Sara I Ramirez-Urrea; Cristian Álvarez
Journal:  Cureus       Date:  2021-11-13

5.  Non-Invasive Skin Imaging Assessment of Human Stress During Head-Down Bed Rest Using a Portable Handheld Two-Photon Microscope.

Authors:  Junjie Wang; Zhen Zhen; Yanqing Wang; Runlong Wu; Yanhui Hu; Qiang Fu; Yongzhi Li; Bingmu Xin; Jinping Song; Jianwei Li; Yafei Ren; Lishuang Feng; Heping Cheng; Aimin Wang; Liming Hu; Shukuan Ling; Yingxian Li
Journal:  Front Physiol       Date:  2022-07-25       Impact factor: 4.755

6.  Case report: Leukemia cutis as the first manifestation of chronic neutrophilic leukemia in a 6-year-old girl.

Authors:  Ya Bin Zhou; Jia Feng Yao; Zi Gang Xu; Rui Hui Wu
Journal:  Front Pediatr       Date:  2022-09-21       Impact factor: 3.569

Review 7.  Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review.

Authors:  Roberto Maglie; Giovanni Genovese; Farzan Solimani; Alba Guglielmo; Alessandro Pileri; Francesca Portelli; Michael Hertl; Angelo Valerio Marzano; Emiliano Antiga
Journal:  Am J Clin Dermatol       Date:  2020-12       Impact factor: 7.403

Review 8.  Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature: Acknowledgments.

Authors:  Yanhong Qiao; Jinli Jian; Lijuan Deng; Hongjuan Tian; Bei Liu
Journal:  Transl Cancer Res       Date:  2020-08       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.